Conditional biallelic Nf 2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2

Hemizygosity for the NF2 gene in humans causes a syndromic susceptibility to schwannoma development. However, Nf2 hemizygous mice do not develop schwannomas but mainly osteosarcomas. In the tumors of both species, the second Nf2 allele is inactivated. We report that conditional homozygous Nf2 knockout mice with Cre-mediated excision of Nf2 exon 2 in Schwann cells showed characteristics of neurofibromatosis type 2. These included schwannomas, Schwann cell hyperplasia, cataract, and osseous metaplasia. Thus, the tumor suppressor function of Nf2, here revealed in murine Schwann cells, was concealed in hemizygous Nf2 mice because of insufficient rate of second allele inactivation in this cell compartment. The finding of this conserved function documents the relevance of the present approach to model the human disease.

[1]  R. Hoess,et al.  Bacteriophage P 1 Site-specific Recombination , 2001 .

[2]  P. Overbeek,et al.  Formation of corneal endothelium is essential for anterior segment development - a transgenic mouse model of anterior segment dysgenesis. , 2000, Development.

[3]  K. Abe,et al.  A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. , 1999, Developmental biology.

[4]  A. Berns,et al.  Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. , 1999, Genes & development.

[5]  A. Berns,et al.  p107 is a suppressor of retinoblastoma development in pRb-deficient mice. , 1998, Genes & development.

[6]  T. Jacks,et al.  Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. , 1998, Genes & development.

[7]  G. Thomas,et al.  Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane. , 1998, Human molecular genetics.

[8]  古閑 比佐志.  Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain , 1998 .

[9]  S. O’Gorman,et al.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Jacks,et al.  The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. , 1997, Genes & development.

[11]  J. Kuratsu,et al.  Neurofibromatosis 2 gene has novel alternative splicings which controls intracellular protein binding. , 1997, International journal of oncology.

[12]  A. Keyser,et al.  [Neurofibromatosis type 2]. , 1997, Nederlands tijdschrift voor geneeskunde.

[13]  T. Jacks.  Tumor suppressor gene mutations in mice. , 1999, Annual review of genetics.

[14]  G. Lemke,et al.  Schwann cell differentiation. , 1996, Current opinion in cell biology.

[15]  J. Gusella,et al.  The merlin tumor suppressor localizes preferentially in membrane ruffles. , 1996, Oncogene.

[16]  J. Minna,et al.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.

[17]  S. Schneider-Maunoury,et al.  Krox-20 controls myelination in the peripheral nervous system , 1994, Nature.

[18]  K. Rajewsky,et al.  Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. , 1994, Science.

[19]  K. Rajewsky,et al.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.

[20]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[21]  N M Le Douarin,et al.  The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. , 1993, Development.

[22]  N. Kley,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. , 1993, Cell.

[23]  N. Sato,et al.  A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. , 1992, Journal of cell science.

[24]  A. Berns,et al.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Palmiter,et al.  P0 promoter directs expression of reporter and toxin genes to schwann cells of transgenic mice , 1992, Neuron.

[26]  Manuel B. Datiles III,et al.  The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. , 1989, Archives of ophthalmology.

[27]  A. Lumsden.  Spatial organization of the epithelium and the role of neural crest cells in the initiation of the mammalian tooth germ. , 1988, Development.

[28]  J. Foncin,et al.  The origin of acoustic neuromas. , 1987, Acta oto-laryngologica.

[29]  J. Woodruff,et al.  Peripheral nerve sheath tumors: An electron microscopic study of 43 cases , 1982, Cancer.

[30]  R. Eldridge.  Central neurofibromatosis with bilateral acoustic neuroma. , 1981, Advances in neurology.

[31]  R. Bolande.  The neurocristopathies: A unifying concept of disease arising in neural crest maldevelopment , 1974 .